Efficacy of CD46-targeting chimeric Ad5/35 adenoviral gene therapy for colorectal cancers.

A novel bladder cancer - specific oncolytic adenovirus by CD46 and its effect combined with cisplatin against cancer cells of CAR negative expression. Virol J (2017) 0.75

Cancer statistics, 2015. CA Cancer J Clin (2015) 57.51

Adenovirus serotype 5 hexon mediates liver gene transfer. Cell (2008) 5.00

Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity. J Virol (2003) 4.48

CD46 is a cellular receptor for group B adenoviruses. Nat Med (2003) 4.35

Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu Rev Immunol (1991) 4.27

The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J Virol (1998) 4.26

Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. Nat Med (2010) 2.58

Adenovirus type 11 uses CD46 as a cellular receptor. J Virol (2003) 2.52

Adenoviruses as gene-delivery vehicles. N Engl J Med (1996) 2.20

The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3. J Virol (2004) 2.11

Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet. J Virol (2004) 1.78

A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells. J Virol (2006) 1.65

A system for the propagation of adenoviral vectors with genetically modified receptor specificities. Nat Biotechnol (1999) 1.39

The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures. Hum Gene Ther (1998) 1.36

Expression of complement inhibitors CD46, CD55, and CD59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphoma. Blood (2001) 1.35

Development of adenovirus serotype 35 as a gene transfer vector. Virology (2003) 1.33

CD46: expanding beyond complement regulation. Trends Immunol (2004) 1.32

Characterization of human adenovirus serotypes 5, 6, 11, and 35 as anticancer agents. Virology (2009) 1.23

Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer. Cancer Res (2014) 1.20

Multimerization of adenovirus serotype 3 fiber knob domains is required for efficient binding of virus to desmoglein 2 and subsequent opening of epithelial junctions. J Virol (2011) 1.17

Characterization of in vitro and in vivo gene transfer properties of adenovirus serotype 35 vector. Mol Ther (2003) 1.14

Human adenoviruses of subgenera B, C, and E with various tropisms differ in both binding to and replication in the epithelial A549 and 293 cells. Virology (2002) 1.09

HOXB13 promotes androgen independent growth of LNCaP prostate cancer cells by the activation of E2F signaling. Mol Cancer (2010) 1.08

Substitution of the adenovirus serotype 5 knob with a serotype 3 knob enhances multiple steps in virus replication. Cancer Res (2003) 1.01

Avidity binding of human adenovirus serotypes 3 and 7 to the membrane cofactor CD46 triggers infection. J Virol (2011) 1.00

Modulation of coxsackie-adenovirus receptor expression for increased adenoviral transgene expression. Cancer Res (2003) 0.99

Treatment of medulloblastoma with a modified measles virus. Neuro Oncol (2010) 0.99

Gene therapy for prostate cancer by controlling adenovirus E1a and E4 gene expression with PSES enhancer. Cancer Res (2005) 0.96

Adenovirus vectors composed of subgroup B adenoviruses. Curr Gene Ther (2007) 0.91

Systematic immunohistochemical analysis of the expression of CD46, CD55, and CD59 in colon cancer. Arch Pathol Lab Med (2014) 0.91

HBXIP upregulates CD46, CD55 and CD59 through ERK1/2/NF-κB signaling to protect breast cancer cells from complement attack. FEBS Lett (2012) 0.90

Do poor-prognosis breast tumours express membrane cofactor proteins (CD46)? Cancer Immunol Immunother (2004) 0.88

Enhanced antitumor efficacy of a novel fiber chimeric oncolytic adenovirus expressing p53 on hepatocellular carcinoma. Cancer Lett (2011) 0.84

Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction. Gene Ther (2013) 0.84

Efficient antitumor effects of carrier cells loaded with a fiber-substituted conditionally replicating adenovirus on CAR-negative tumor cells. Cancer Gene Ther (2011) 0.83

Hepatitis B virus X protein protects hepatoma and hepatic cells from complement-dependent cytotoxicity by up-regulation of CD46. FEBS Lett (2013) 0.82

Transduction and oncolytic profile of a potent replication-competent adenovirus 11p vector (RCAd11pGFP) in colon carcinoma cells. PLoS One (2011) 0.81

ABC of colorectal cancer: Innovative treatment for colon cancer. BMJ (2000) 0.80

Modification of the early gene enhancer-promoter improves the oncolytic potency of adenovirus 11. Mol Ther (2011) 0.79

Adenovirus serotype 11 causes less long-term intraperitoneal inflammation than serotype 5: implications for ovarian cancer therapy. Virology (2013) 0.79

Serotype chimeric human adenoviruses for cancer gene therapy. Viruses (2010) 0.78

CD46 Expression is an unfavorable prognostic factor in breast cancer cases. Appl Immunohistochem Mol Morphol (2011) 0.77

Replication-competent adenoviruses with the type 35-derived fiber-knob region achieve reactive oxygen species-dependent cytotoxicity and produce greater toxicity than those with the type 5-derived region in pancreatic carcinoma. Apoptosis (2015) 0.76

Cyclooxygenase-2 overexpression correlates with vascular endothelial growth factor expression and tumor angiogenesis in gastric cancer. J Clin Gastroenterol (2003) 2.03

Expression of cyclooxygenase-2 protein in colorectal carcinomas. Int J Gastrointest Cancer (2002) 1.06

Cyclooxygenase-2 expression is associated with well-differentiated and intestinal-type pathways in gastric carcinogenesis. Digestion (2002) 1.02

Protective effect of diallyl disulfide on cyclophosphamide-induced testicular toxicity in rats. Lab Anim Res (2013) 0.85

Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: a nationwide multicenter prospective study in Korea. Gut Liver (2013) 0.83

Increased Expression of Brain-derived Neurotrophic Factor in Irritable Bowel Syndrome and Its Correlation With Abdominal Pain (Gut 2012;61:685-694). J Neurogastroenterol Motil (2013) 0.82

Protective effects of pine bark extract against cisplatin-induced hepatotoxicity and oxidative stress in rats. Lab Anim Res (2014) 0.78

Natural product-derived drugs for the treatment of inflammatory bowel diseases. Intest Res (2014) 0.78

Chemical induction of unfolded protein response enhances cancer cell killing through lytic virus infection. J Virol (2014) 0.78

Parathyroid cyst presenting as acute pancreatitis: report of a case. Chonnam Med J (2013) 0.78

Association between interleukin-18 gene polymorphism and Helicobacter pylori infection in the Korean population. Sci Rep (2015) 0.75

Risk of advanced colorectal neoplasm in patients with more than 10 adenomas on index colonoscopy: A Korean Association for the Study of Intestinal Diseases (KASID) Study. J Gastroenterol Hepatol (2016) 0.75

Clinicopathological features of laterally spreading colorectal tumors and their association with advanced histology and invasiveness: An experience from Honam province of South Korea: A Honam Association for the Study of Intestinal Diseases (HASID). PLoS One (2017) 0.75

Gastric and splenic infarctions in acute pancreatitis. J Dig Dis (2016) 0.75